23 Jul Virica Biotech
Jean-Simon Diallo, CEO and Scientific Founder
Oct. 6 | 4:00pm | FLW Ballroom G
Ontario, Canada
(Private)
Virica Biotech is an enabling technology company that has developed Viral Sensitizer (VSE™) technology, a novel class of biomanufacturing enhancers designed to improve the yield, quality, and scalability of viral vector manufacturing for cell and gene therapies and vaccines. Unlike traditional process additives, VSEs work through a distinct mechanism by addressing cellular defenses that limit viral vector production efficiency. VSE technology is classified as an ancillary material, allowing developers to layer it into existing processes without disruption. Virica’s commercially available CellVantage™ product line gives developers off-the-shelf access to VSE technology across AAV and lentiviral applications. Virica also partners with industry developers on process optimization through its proprietary High-Throughput Virology (HTV™) platform, supporting faster scale-up for cell and gene therapy and vaccine programs.